Rendomab B4, a monoclonal antibody that discriminates the human endothelin B receptor of melanoma cells and inhibits their migration.
about
Rendomab B4, a monoclonal antibody that discriminates the human endothelin B receptor of melanoma cells and inhibits their migration.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rendomab B4, a monoclonal anti ...... and inhibits their migration.
@en
Rendomab B4, a monoclonal anti ...... and inhibits their migration.
@nl
type
label
Rendomab B4, a monoclonal anti ...... and inhibits their migration.
@en
Rendomab B4, a monoclonal anti ...... and inhibits their migration.
@nl
prefLabel
Rendomab B4, a monoclonal anti ...... and inhibits their migration.
@en
Rendomab B4, a monoclonal anti ...... and inhibits their migration.
@nl
P2093
P2860
P1476
Rendomab B4, a monoclonal anti ...... and inhibits their migration.
@en
P2093
Amaury Herbet
Anne Wijkhuisen
Aurélie Borrull
Bertrand Allard
Denis Leiber
Didier Boquet
Frédéric Ducancel
Jean-Yves Couraud
Patricia Lamourette
Philippe Robin
P2860
P304
P356
10.1080/19420862.2016.1208865
P577
2016-07-08T00:00:00Z